MindMed | Investor Day Presentation Deck | 61 slides

MindMed · 2023-06
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 5
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON

Slide inventory

61
every slide · same image gating as the playbook
01
Slide 1
front_matter
03
front_matter
04
summarize
Open slide detailLoop · Golden Circle
05
The slide uses a visual metaphor of a brain with focal points connecting to three key pillars of the drug's profile.summarize
Open slide detailLoop · Golden Circle
06
The slide uses a bar chart for CNS sales projections and a horizontal bar chart to benchmark CAGR against other therapeutic areas.size_opportunity
Open slide detailLoop · Golden Circle
07
analyze_data
Open slide detailBeat · Market Size
08
The slide uses USPSTF clinical guidelines to establish the market/clinical importance of anxiety screening.cite_precedent
Open slide detailBeat · Market Size
09
The slide highlights market positioning by contrasting established drugs with emerging pipeline assets.compare_peers
Open slide detailBeat · Market Size
10
The chart shows a significant historical peak in LSD research in the 1960s/70s followed by a decline and recent resurgence alongside psilocybin.size_opportunity
11
Includes a screenshot of a press release as evidence of the enrollment milestone.summarize
Open slide detailBeat · Product
12
The chart is a visual representation of market exclusivity duration, not a standard bar chart, using discrete blocks to represent years.present_framework
Open slide detailBeat · Product
13
transition
Open slide detailBeat · Product
14
Includes a disclaimer at the bottom regarding the speaker's affiliation with MindMed's Scientific Advisory Board.introduce_nominees
Open slide detailBeat · Product
15
Uses a nested circle diagram to illustrate the patient population funnel.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
16
diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
17
diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
18
The slide illustrates a standard psychiatric treatment escalation model.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
19
The slide uses a comparison table to establish the 'problem' of current standard-of-care limitations.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
20
summarize
Open slide detailBeat · Agitate (Make it worse)
21
front_matter
Open slide detailBeat · Agitate (Make it worse)
22
introduce_nominees
Open slide detailBeat · Agitate (Make it worse)
23
establish_context
Open slide detailBeat · Agitate (Make it worse)
24
present_solution
Open slide detailBeat · Agitate (Make it worse)
25
The slide serves as a visual case study to ground the audience in the physical reality of the therapy delivery.illustrate_case
Open slide detailBeat · Agitate (Make it worse)
26
The slide uses a linear process diagram to explain the clinical workflow.present_framework
Open slide detailBeat · Solution (Provide relief)
27
The slide uses a before-after framework to explain the commercial trajectory of the drug.analyze_data
Open slide detailBeat · Solution (Provide relief)
28
establish_context
Open slide detailBeat · Solution (Provide relief)
29
summarize
Open slide detailBeat · Solution (Provide relief)
30
transition
Open slide detailBeat · Solution (Provide relief)
31
front_matter
32
introduce_nominees
33
frame_problem
34
size_opportunity
35
The chart uses a stacked bar comparison to show the disparity between population share and cost share.diagnose_problem
36
establish_context
37
frame_situation
38
cite_precedent
39
front_matter
40
introduce_nominees
41
The slide uses a horizontal bar chart to represent a timeline of patent life.establish_context
42
The slide explains the interplay between different regulatory exclusivity periods (NCE, PED, QIDP) and the 30-month stay mechanism.establish_context
43
establish_context
44
establish_context
45
establish_context
46
front_matter
47
summarize
Open slide detailLoop · Mece Breakdown
48
The slide uses a grid layout to associate each executive with a column of professional logos.introduce_nominees
Open slide detailLoop · Mece Breakdown
49
The slide uses a grid layout to associate each leader with a column of logos representing their past experience.introduce_nominees
Open slide detailLoop · Mece Breakdown
50
The slide uses a Gantt-style chart to show the progress of various drug candidates through clinical development stages.plan_implementation
Open slide detailLoop · Mece Breakdown
51
The slide uses a before-after visual comparison of brain connectivity to illustrate the mechanism of action.present_framework
52
cite_precedent
53
The chart displays STAI-G scores over 24 weeks, highlighting a statistically significant divergence between the LSD and placebo groups.analyze_data
54
The chart shows a clear dose-response relationship with high dose performing significantly better than low dose.analyze_data
55
The slide uses a timeline-based study design diagram to illustrate the randomization and follow-up periods.present_framework
56
summarize
57
The slide uses a chronological process flow to describe the patient experience.present_framework
58
present_framework
59
The slide uses a process-oriented layout to define the commercialization strategy.plan_implementation
60
summarize
61
transition